Literature DB >> 14586892

The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.

Edward Gane1.   

Abstract

1. Recurrence of hepatitis C infection is universal and immediate after liver transplantation. 2. Graft and patient survival is reduced in liver transplantation recipients with recurrent hepatitis C virus infection compared with hepatitis C virus-negative recipients. 3. The natural history of chronic hepatitis C is accelerated after liver transplantation compared with nontransplantation chronic hepatitis C; 20% to 40% of patients progress to allograft cirrhosis within 5 years, compared with less than 5% of nontransplantation patients. 4. The rate of fibrosis progression is not uniform and may change over time. 5. The rate of progression from cirrhosis to decompensation is accelerated after liver transplantation. The rate of decompensation is >40% at 1 year and >60% at 3 years, compared with <5% and <10%, respectively, in immunocompetent patients. 6. The rate of progression from decompensation to death is also accelerated after liver transplantation. The 3-year survival is <10% after the onset of hepatitis C virus-related allograft failure, compared with 60% after decompensation in immunocompetent patients.

Entities:  

Mesh:

Year:  2003        PMID: 14586892     DOI: 10.1053/jlts.2003.50248

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  37 in total

1.  Transplantation for alcoholic liver disease.

Authors:  Kerry Webb; James Neuberger
Journal:  BMJ       Date:  2004-07-10

2.  Hepatitis C and liver transplantation.

Authors:  G Tsoulfas; I Goulis; D Giakoustidis; E Akriviadis; P Agorastou; G Imvrios; V Papanikolaou
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

3.  Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C.

Authors:  Winston Dunn; Maura O'Neil; Jie Zhao; Chuang Hong Wu; Benjamin Roberts; Shweta Chakraborty; Craig Sherman; Brandy Weaver; Ryan Taylor; Jody Olson; Mojtaba Olyaee; Richard Gilroy; Timothy Schmitt; Yu-Jui Yvonne Wan; Steven A Weinman
Journal:  Hepatology       Date:  2013-12-23       Impact factor: 17.425

4.  MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants.

Authors:  Ryan B Perumpail; Josh Levitsky; Yi Wang; Victoria S Lee; Jennifer Karp; Ning Jin; Guang-Yu Yang; Bradley D Bolster; Saurabh Shah; Sven Zuehlsdorff; Albert A Nemcek; Andrew C Larson; Frank H Miller; Reed A Omary
Journal:  Acad Radiol       Date:  2012-09       Impact factor: 3.173

5.  Effect of tacrolimus on survival in hepatitis C-infected patients after liver transplantation.

Authors:  Jacqueline G O'Leary; James F Trotter; Michael A Neri; Linda W Jennings; Greg J McKenna; Gary L Davis; Göran B Klintmalm
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-07

Review 6.  Living donor liver transplantation for hepatitis C.

Authors:  Yasutsugu Takada; Shinji Uemoto
Journal:  Surg Today       Date:  2012-10-06       Impact factor: 2.549

7.  Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.

Authors:  Maricar F Malinis; Shu Chen; Heather G Allore; Vincent J Quagliarello
Journal:  Ann Transplant       Date:  2014-09-26       Impact factor: 1.530

Review 8.  Evidence-based clinical practice guidelines for liver cirrhosis 2015.

Authors:  Hiroshi Fukui; Hidetsugu Saito; Yoshiyuki Ueno; Hirofumi Uto; Katsutoshi Obara; Isao Sakaida; Akitaka Shibuya; Masataka Seike; Sumiko Nagoshi; Makoto Segawa; Hirohito Tsubouchi; Hisataka Moriwaki; Akinobu Kato; Etsuko Hashimoto; Kojiro Michitaka; Toshikazu Murawaki; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-05-31       Impact factor: 7.527

Review 9.  Management of hepatitis C infection before and after liver transplantation.

Authors:  Stefano Fagiuoli; Roberto Ravasio; Maria Grazia Lucà; Anna Baldan; Silvia Pecere; Alessandro Vitale; Luisa Pasulo
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

10.  Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.

Authors:  Arun Jesudian; Sameer Desale; Jonathan Julia; Elizabeth Landry; Christopher Maxwell; Bhaskar Kallakury; Jacqueline Laurin; Kirti Shetty
Journal:  J Clin Exp Hepatol       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.